Search / Trial NCT00002264

The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea

Launched by STOLLE MILK BIOLOGIC INTERNATIONAL · Aug 30, 2001

Trial Information

Current as of November 03, 2024

Completed

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Patients must have:
  • * Diagnosis of diarrhea associated with intestinal cryptosporidiosis.
  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with the following conditions or symptoms are excluded:
  • * Survival time projected to be \< 9 weeks.
  • * Inability to tolerate any oral intake.
  • * Known allergy or intolerance to milk products.
  • * Organic mental syndrome precluding informed consent or following directions.
  • Patients with the following are excluded:
  • * Survival time projected to be \< 9 weeks.
  • * Inability to tolerate any oral intake.
  • * Known allergy or intolerance to milk products.
  • * Organic mental syndrome precluding informed consent or following directions.

About Stolle Milk Biologic International

Stolle Milk Biologic International is a leading clinical trial sponsor dedicated to advancing innovative therapies in the field of biotechnology, with a focus on developing biologic products derived from milk. Committed to rigorous research and development, the organization collaborates with academic institutions and industry partners to conduct cutting-edge clinical trials that aim to improve patient outcomes and address unmet medical needs. With a strong emphasis on quality, safety, and ethical standards, Stolle Milk Biologic International strives to translate scientific discoveries into effective therapeutic solutions, positioning itself as a pioneer in the biologics landscape.

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials